Advocates push province to fund pancreatic cancer drug, as surge in late-stage diagnoses predicted

Nova Scotia patient advocates are urging governments to reconsider funding a drug that is clinically proven to extend the lives of pancreatic cancer patients. As Elizabeth McSheffrey reports, their push comes as experts predict a surge in late-stage cancer diagnoses in 2021, due to a lack of screening and cancer services in the first wave of the COVID-19 pandemic.

• Advocates push province to fund pancreatic cancer drug as surge in late-stage diagnoses predicted